Revance AestheticsArticles & NewsInjectablesRevance Publishes Two Peer-reviewed Articles on Glabellar Line Injection TechniquesThe articles highlight the nuances of glabellar line (GL) injection technique and aim to improve patient outcomes, irrespective of the neuromodulator used.NewsClaytor Noone Plastic Surgery Selected for Pre-Launch of Neuromodulator DAXXIFYThe board certified plastic surgeon and his team of providers are proud to be one of the few medical spas in the Philadelphia area chosen to be a part of DAXXIFY's early release.NewsAllegro MedSpa of Santa Rosa, CA One of the First Practices to Offer DAXXIFYRevance Aesthetics is first releasing DAXXIFY to only the top 1% of neuromodulator injecting practices nationwide, making Allegro MedSpa one of only six Northern California practices to offer DAXXIFY ahead of its official release in the summer of 2023.ResearchTwo Peer-Reviewed Articles Highlight Efficacy and Safety of DAXXIFYThe two studies confirmed DAXXIFY is a safe, effective and long-lasting treatment for frown lines in adult patients of all ages and skin types.Collagen BuildersRevance Therapeutics Receives FDA Approval for DAXXIFYDAXXIFY is the first and only neuromodulator stabilized with Peptide Exchange Technology (PXT) and is free of both human serum albumin and animal-based components.NewsRevance Therapeutics Showcase New Abstracts at 2022 Toxins International ConferenceHighlights include data demonstrating the enhancement of membrane binding of the core toxin of BoNT/A via Revance’s peptide excipient, RTP004.
